|
1
|
The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.
|
J Immunol
|
2004
|
2.19
|
|
2
|
Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE).
|
J Biol Chem
|
2003
|
2.05
|
|
3
|
Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules.
|
Comb Chem High Throughput Screen
|
2005
|
1.99
|
|
4
|
Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis.
|
J Immunol
|
2011
|
1.79
|
|
5
|
Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.
|
J Neurochem
|
2005
|
1.28
|
|
6
|
Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.
|
J Invest Dermatol
|
2007
|
1.13
|
|
7
|
A systems model for immune cell interactions unravels the mechanism of inflammation in human skin.
|
PLoS Comput Biol
|
2010
|
1.07
|
|
8
|
Integrative biology approach identifies cytokine targeting strategies for psoriasis.
|
Sci Transl Med
|
2014
|
0.89
|
|
9
|
An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element.
|
PLoS One
|
2013
|
0.86
|
|
10
|
Computational modelling elucidates the mechanism of ciliary regulation in health and disease.
|
BMC Syst Biol
|
2011
|
0.77
|